229 related articles for article (PubMed ID: 8108174)
1. Correlation between specific IgG subclass antibodies to Pseudomonas aeruginosa and opsonic activity in serum from patients with cystic fibrosis.
Pressler T; Jensen ET; Espersen F; Pedersen SS; Høiby N; Koch C
Pediatr Pulmonol; 1994 Jan; 17(1):31-40. PubMed ID: 8108174
[TBL] [Abstract][Full Text] [Related]
2. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
[TBL] [Abstract][Full Text] [Related]
3. Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection.
Tosi MF; Zakem-Cloud H; Demko CA; Schreiber JR; Stern RC; Konstan MW; Berger M
J Infect Dis; 1995 Aug; 172(2):453-61. PubMed ID: 7622889
[TBL] [Abstract][Full Text] [Related]
4. IgG subclass antibody responses to alginate from Pseudomonas aeruginosa in patients with cystic fibrosis and chronic P. aeruginosa infection.
Pressler T; Pedersen SS; Espersen F; Høiby N; Koch C
Pediatr Pulmonol; 1992 Sep; 14(1):44-51. PubMed ID: 1437343
[TBL] [Abstract][Full Text] [Related]
5. IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Ps. aeruginosa infection investigated by ELISA.
Pressler T; Pedersen SS; Espersen F; Høiby N; Koch C
Clin Exp Immunol; 1990 Sep; 81(3):428-34. PubMed ID: 2118845
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide.
Fick RB; Olchowski J; Squier SU; Merrill WW; Reynolds HY
Am Rev Respir Dis; 1986 Mar; 133(3):418-22. PubMed ID: 3082264
[TBL] [Abstract][Full Text] [Related]
7. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
Meluleni GJ; Grout M; Evans DJ; Pier GB
J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
[TBL] [Abstract][Full Text] [Related]
8. The role of IgG subclass antibodies in chronic infection: the case of cystic fibrosis.
Moss RB
N Engl Reg Allergy Proc; 1988; 9(1):57-61. PubMed ID: 3362109
[TBL] [Abstract][Full Text] [Related]
9. Anti-Pseudomonas aeruginosa IgG subclass titers in patients with cystic fibrosis: correlations with pulmonary function, neutrophil chemotaxis, and phagocytosis.
Cowan RG; Winnie GB
J Clin Immunol; 1993 Sep; 13(5):359-70. PubMed ID: 8245182
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin allotypes and IgG subclass antibody response to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients.
Pressler T; Pandey JP; Espersen F; Pedersen SS; Fomsgaard A; Koch C; Høiby N
Clin Exp Immunol; 1992 Nov; 90(2):209-14. PubMed ID: 1424275
[TBL] [Abstract][Full Text] [Related]
11. Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa.
Pier GB; Takeda S; Grout M; Markham RB
J Clin Invest; 1993 Mar; 91(3):1079-87. PubMed ID: 8450038
[TBL] [Abstract][Full Text] [Related]
12. Correlation of serum opsonic activity in cystic fibrosis with colonization and disease state: measurement of opsonins to Pseudomonas aeruginosa by neutrophil superoxide anion generation.
Bender JG; Florman AL; Van Epps DE
Pediatr Res; 1987 Oct; 22(4):383-8. PubMed ID: 2825106
[TBL] [Abstract][Full Text] [Related]
13. Opsonization of mucoid and non-mucoid Pseudomonas aeruginosa by serum from patients with cystic fibrosis assessed by a chemiluminescence assay.
LeBlanc CM; Bortolussi R; Issekutz AC; Gillespie T
Clin Invest Med; 1982; 5(2-3):125-8. PubMed ID: 6811181
[TBL] [Abstract][Full Text] [Related]
14. Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.
Fick RB; Naegel GP; Squier SU; Wood RE; Gee JB; Reynolds HY
J Clin Invest; 1984 Jul; 74(1):236-48. PubMed ID: 6429195
[TBL] [Abstract][Full Text] [Related]
15. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
Pier GB
Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the adherence of Pseudomonas aeruginosa to epithelial cells by IgG subclass antibodies.
Morrin M; Reen DJ
J Med Microbiol; 1993 Dec; 39(6):459-66. PubMed ID: 8246266
[TBL] [Abstract][Full Text] [Related]
17. The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion.
Hornick DB; Fick RB
J Clin Invest; 1990 Oct; 86(4):1285-92. PubMed ID: 2120286
[TBL] [Abstract][Full Text] [Related]
18. Association with phagocytic inhibition of anti-Pseudomonas aeruginosa immunoglobulin G antibody subclass levels in serum from patients with cystic fibrosis.
Shryock TR; Mollé JS; Klinger JD; Thomassen MJ
J Clin Microbiol; 1986 Mar; 23(3):513-6. PubMed ID: 3082922
[TBL] [Abstract][Full Text] [Related]
19. The influence of allotypes on the IgG subclass response to chromosomal beta-lactamase of Pseudomonas aeruginosa in cystic fibrosis patients.
Ciofu O; Pressler T; Pandey JP; Høiby N
Clin Exp Immunol; 1997 Apr; 108(1):88-94. PubMed ID: 9097916
[TBL] [Abstract][Full Text] [Related]
20. Relative increase in IgG antibodies to Pseudomonas aeruginosa 60-kDa GroEL in prediabetic patients with cystic fibrosis.
Jensen P; Johansen HK; Lanng S; Høiby N
Pediatr Res; 2001 Mar; 49(3):423-8. PubMed ID: 11228271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
